Novel solutions driving discovery
Optimer™ technology delivers novel solutions, that meet the needs of researchers and developers, to drive discovery across the life sciences.
Optimers are next-generation aptamer molecules derived from nucleic acids that function as an antibody alternative. Our unique approach to Optimer selection offers novel aptamers tailored explicitly for each custom project. We start with the end in mind: The specific application characteristics and performance requirements are integrated into our Optimer selection and development processes, resulting in a truly customized solution. This simplifies the downstream integration of Optimer ligands into their intended therapeutic, diagnostic or research application. Optimers perform well in a variety of in vitro and in vivo assays and application formats across a number of different platforms from discovery through development.